Provision of antiretroviral therapy in South Africa: the nuts and bolts

Hdl Handle:
http://hdl.handle.net/10144/336372
Title:
Provision of antiretroviral therapy in South Africa: the nuts and bolts
Authors:
Bekker, Linda-Gail; Venter, Francois; Cohen, Karen; Goemare, Eric; Van Cutsem, Gilles; Boulle, Andrew; Wood, Robin
Journal:
Antiviral Therapy
Abstract:
Public sector antiretroviral provision had a slow start in South Africa despite a raging epidemic and a World AIDS conference that shed significant public light on the disparities of therapy access globally. This was largely due to political prevarication in the midst of AIDS denialism. There has been an unprecedented expansion in the HIV treatment programme since 2008. As a result, South Africa now has the largest number of patients on antiretroviral drugs in the world, and South African life expectancy has increased by more than a decade. However, this has led to a number of fiscal, logistic and operational challenges that the country must face as the treatment programme continues to expand. Challenges include increasing detection within communities, linkage and retention in care, while strengthening operational support functions such as consistent drug supply, health staffing and infrastructure, diagnostic services, programme monitoring and sustainable financing. As a middle-income country, albeit with marked income inequality, and the heaviest HIV burden in the world, South Africa is a test case of whether a large-scale public health programme can boast of success in the face of numerous other health-system challenges.
Publisher:
International Medical Press
Issue Date:
13-Oct-2014
URI:
http://hdl.handle.net/10144/336372
DOI:
10.3851/IMP2905
PubMed ID:
25310359
Additional Links:
http://www.intmedpress.com
Language:
en
ISSN:
2040-2058
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorBekker, Linda-Gailen_GB
dc.contributor.authorVenter, Francoisen_GB
dc.contributor.authorCohen, Karenen_GB
dc.contributor.authorGoemare, Ericen_GB
dc.contributor.authorVan Cutsem, Gillesen_GB
dc.contributor.authorBoulle, Andrewen_GB
dc.contributor.authorWood, Robinen_GB
dc.date.accessioned2014-11-30T15:38:18Z-
dc.date.available2014-11-30T15:38:18Z-
dc.date.issued2014-10-13-
dc.identifier.citationProvision of antiretroviral therapy in South Africa: the nuts and bolts. 2014, 19 Suppl 3:105-16 Antivir. Ther. (Lond.)en_GB
dc.identifier.issn2040-2058-
dc.identifier.pmid25310359-
dc.identifier.doi10.3851/IMP2905-
dc.identifier.urihttp://hdl.handle.net/10144/336372-
dc.description.abstractPublic sector antiretroviral provision had a slow start in South Africa despite a raging epidemic and a World AIDS conference that shed significant public light on the disparities of therapy access globally. This was largely due to political prevarication in the midst of AIDS denialism. There has been an unprecedented expansion in the HIV treatment programme since 2008. As a result, South Africa now has the largest number of patients on antiretroviral drugs in the world, and South African life expectancy has increased by more than a decade. However, this has led to a number of fiscal, logistic and operational challenges that the country must face as the treatment programme continues to expand. Challenges include increasing detection within communities, linkage and retention in care, while strengthening operational support functions such as consistent drug supply, health staffing and infrastructure, diagnostic services, programme monitoring and sustainable financing. As a middle-income country, albeit with marked income inequality, and the heaviest HIV burden in the world, South Africa is a test case of whether a large-scale public health programme can boast of success in the face of numerous other health-system challenges.en_GB
dc.language.isoenen
dc.publisherInternational Medical Pressen_GB
dc.relation.urlhttp://www.intmedpress.comen_GB
dc.rightsArchived on this site with kind permission of International Medical Press. http://www.intmedpress.comen_GB
dc.titleProvision of antiretroviral therapy in South Africa: the nuts and boltsen
dc.identifier.journalAntiviral Therapyen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.